Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
AEG35156 and Docetaxel in Treating Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel in Locally Advanced Gastric Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
- Status
- COMPLETED
- Phase
- PHASE3